The U.S. Senate is in session for three days this week while the U.S. House of Representatives is in recess all week. Both chambers will return for a week before breaking for the July 4 recess. Negotiations on the...more
6/18/2025
/ Budget Reconciliation ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Healthcare ,
Healthcare Reform ,
Medicaid ,
Medical Research ,
Medicare ,
MedPAC ,
National Institute of Health (NIH) ,
Proposed Legislation
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
3/12/2025
/ Affordable Care Act ,
CBO Report ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Federal Funding ,
Food and Drug Administration (FDA) ,
General Services Administration (GSA) ,
GRAS ,
Health Care Providers ,
Legislative Agendas ,
Medicare ,
Tariffs
Holland & Knight Health Dose Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/26/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Department of Government Efficiency (DOGE) ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health ,
Regulatory Agenda ,
Regulatory Requirements ,
Tariffs
The Centers for Medicare & Medicaid Services (CMS) has released the calendar year (CY) 2025 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Final Rule with comment...more
11/7/2024
/ Ambulatory Surgery Centers ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Department of Health and Human Services (HHS) ,
Final Rules ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Hospitals ,
Inpatient Prospective Payment System (IPPS) ,
Medical Devices ,
Medicare ,
Outpatient Prospective Payment System (OPPS) ,
Payment Rates ,
Prescription Drugs ,
Rural Health Care Providers ,
Tribal Government Programs
For nearly 40 years and in more than 18,000 judicial opinions, federal courts have used the Chevron doctrine to defer to an agency's reasonable interpretation of an ambiguous statute. On June 28, 2024, the U.S. Supreme Court...more
9/3/2024
/ Administrative Procedure Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Chevron Deference ,
Chevron v NRDC ,
Consumer Financial Protection Bureau (CFPB) ,
Corner Post Inc v Board of Governors of the Federal Reserve System ,
Department of Justice (DOJ) ,
Department of Labor (DOL) ,
Department of Transportation (DOT) ,
Environmental Protection Agency (EPA) ,
Federal Trade Commission (FTC) ,
FERC ,
Food and Drug Administration (FDA) ,
Government Agencies ,
HUD ,
IRS ,
Judicial Authority ,
Loper Bright Enterprises v Raimondo ,
NTSB ,
OCC ,
Popular ,
Regulatory Authority ,
Relentless Inc v US Department of Commerce ,
SCOTUS ,
Stare Decisis ,
Statute of Limitations ,
Statutory Interpretation ,
U.S. Treasury
The U.S. Supreme Court issued a significant ruling on June 28, 2024, that changes the respective roles of administrative agencies and the courts in interpreting statutes. In Loper Bright Enterprises v. Raimondo, the court...more
7/5/2024
/ Administrative Procedure Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Chevron Deference ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Government Agencies ,
Health Care Providers ,
Loper Bright Enterprises v Raimondo ,
OCR ,
Regulatory Authority ,
SCOTUS ,
Statutory Interpretation
The Centers for Medicare & Medicaid Services (CMS) on April 10, 2024, released a proposed rule for the fiscal year (FY) 2025 Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System...more
4/17/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Coding ,
Food and Drug Administration (FDA) ,
Graduate Medical Education ,
Health Care Providers ,
Hospitals ,
Inpatient Prospective Payment System (IPPS) ,
Long-Term Care ,
Medical Coding ,
Medicare ,
Payment Rates ,
Proposed Rules ,
Public Health Emergency ,
Rural Health Care Providers
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
12/15/2023
/ Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Cybersecurity ,
Drug Pricing ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Interim Final Rules (IFR) ,
Medicaid ,
Medicare ,
Medicare Part B ,
MedPAC ,
OMB ,
Pending Legislation ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Private Equity ,
Private Equity Firms ,
Resignation ,
Transparency
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
...more
11/1/2023
/ Artificial Intelligence ,
Biden Administration ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Elder Issues ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
HRSA ,
Legislative Agendas ,
National Institute of Health (NIH) ,
No Surprises Act (NSA) ,
Pharmaceutical Industry ,
Proposed Rules ,
Speaker of the House
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
...more
10/18/2023
/ Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Deductibles ,
Department of Health and Human Services (HHS) ,
Final Rules ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Hospitals ,
Information Reports ,
Medicare ,
Medicare Part A ,
Medicare Part B ,
National Institute of Health (NIH) ,
Nonprofits ,
Outpatient Prospective Payment System (OPPS) ,
Pfizer ,
Physician Fee Schedule ,
Premiums ,
Presidential Nominations ,
Public Policy ,
Section 340B ,
Speaker of the House
The Centers for Medicare & Medicaid Services (CMS) recently issued a long-awaited Notice with Comment Period outlining a proposed Transitional Coverage for Emerging Technologies (TCET) pathway under Medicare that would be...more
7/14/2023
/ Administrative Procedure ,
Centers for Medicare & Medicaid Services (CMS) ,
Emerging Technologies ,
Expedited Approval Process ,
Food and Drug Administration (FDA) ,
MACs ,
Medical Devices ,
Medicare ,
New Guidance ,
Notice and Comment ,
Rulemaking Process
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
...more
6/22/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
MACPAC ,
Medicare ,
Medicare Part D ,
MedPAC ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics...more
4/24/2023
/ Artificial Intelligence ,
Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Inpatient Prospective Payment System (IPPS) ,
National Cancer Moonshot ,
Physician Fee Schedule ,
Prescription Drugs ,
Proposed Legislation ,
Public Health Emergency
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include...more
2/9/2023
/ Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicaid ,
Medicare ,
New Guidance ,
Pending Legislation ,
Pharmacies ,
Public Health Emergency ,
Section 340B ,
State of the Union
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include: ...more
1/26/2023
/ ACOs ,
Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
CMMI ,
Congressional Committees ,
Congressional Oversight ,
Coronavirus/COVID-19 ,
Drug Pricing ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicare Shared Savings Program ,
National Institute of Health (NIH) ,
Prescription Drugs
Lawmakers unveiled their long-awaited $1.7 trillion government funding package on Dec. 20, 2022. As of publishing, it seems likely that a vote on final passage in the U.S. Senate will occur at some point on Dec. 22, with a...more
12/22/2022
/ Centers for Disease Control and Prevention (CDC) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Infectious Diseases ,
Medicare ,
Mental Health ,
National Institute of Health (NIH) ,
Prescription Drugs ,
Public Health ,
SAMHSA
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include: ...more
12/15/2022
/ Centers for Medicare & Medicaid Services (CMS) ,
Continuing Resolution ,
Federal Funding ,
Federally Facilitated Exchanges ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Innovation ,
International Standards ,
Legislative Agendas ,
Medicaid ,
Medicare ,
New Guidance ,
Physician Medicare Reimbursements ,
Prior Authorization ,
Proposed Rules
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
...more
10/19/2022
/ Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Executive Orders ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Inflation Reduction Act (IRA) ,
Medicare ,
Prescription Drugs ,
Public Health Emergency ,
Section 340B ,
Vaccinations
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics...more
10/5/2022
/ Biden Administration ,
CBO Report ,
Centers for Medicare & Medicaid Services (CMS) ,
Commercial Insurance Policies ,
Continuing Resolution ,
FDA Approval ,
Federal Budget ,
FEMA ,
Food and Drug Administration (FDA) ,
Government Shutdown ,
Health Clinics ,
Medicaid ,
Medicare Part A ,
Medicare Part B ,
Premiums ,
Prescription Drugs ,
Public Health ,
Telehealth
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics...more
7/14/2022
/ Bias ,
Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Expedited Approval Process ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Pharmaceutical Industry ,
Portal ,
Price Transparency ,
Reporting Requirements ,
Transparency
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include ...more
6/23/2022
/ Congressional Committees ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
Data Collection ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Medicare ,
Mental Health ,
OIG ,
Reimbursements ,
SCOTUS ,
Telehealth ,
User Fees ,
Vaccinations ,
Veterans
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include . . ....more
6/9/2022
/ Centers for Medicare & Medicaid Services (CMS) ,
Compliance ,
Department of Health and Human Services (HHS) ,
Environmental Justice ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Legislative Agendas ,
Medicare ,
ONC ,
Quality of Care Standards ,
Surprise Medical Bills ,
Vaccinations ,
World Health Organization
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
...more
5/17/2022
/ China ,
Congressional Committees ,
Coronavirus/COVID-19 ,
Food and Drug Administration (FDA) ,
HRSA ,
Humanitarian Assistance ,
Innovation Act ,
Mental Health ,
Military Conflict ,
Military Lending Act ,
Pregnancy ,
Proposed Legislation ,
Public Health Emergency ,
Regulatory Requirements ,
Relief Measures ,
SAMHSA ,
Substance Abuse ,
Ukraine ,
User Fees ,
Workplace Violence ,
Workplace Violence Prevention Programs
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
...more
A presidential race called by media outlets for former Vice President Joe Biden, coupled with a diminished Democratic majority in the U.S. House of Representatives and a narrowly divided Senate, translates into a federal...more
11/12/2020
/ Affordable Care Act ,
Biden Administration ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Food and Drug Administration (FDA) ,
Healthcare Reform ,
Judicial Appointments ,
Legislative Agendas ,
Presidential Elections ,
Public Policy ,
Regulatory Agenda